Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study
Crossref DOI link: https://doi.org/10.1007/s00125-015-3652-2
Published Online: 2015-06-09
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ong, Kwok-Leung
,
Januszewski, Andrzej S.
O’Connell, Rachel
Buizen, Luke
Jenkins, Alicia J.
Xu, Aimin
Sullivan, David R.
Barter, Philip J.
Scott, Russell S.
Taskinen, Marja-Riitta
Rye, Kerry-Anne
Keech, Anthony C.
Text and Data Mining valid from 2015-06-09